Evidence map›Paper›PMID 24971933›Full record

ArticleNeurobiology of disease2014

Central P2Y12 receptor blockade alleviates inflammatory and neuropathic pain and cytokine production in rodents.

Gergely Horváth, Flóra Gölöncsér, Cecilia Csölle, Kornél Király, Rómeó D Andó, Mária Baranyi, Bence Koványi, Zoltán Máté, Kristina Hoffmann, Irina Algaier and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Neurobiology of disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Gergely HorváthLaboratory of Molecular Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1083 Budapest, Szigony u. 43, Hungary; János Szentágothai School of Neurosciences, Semmelweis University School of Ph.D Studies, Budapest, Hungary.
Flóra GölöncsérLaboratory of Molecular Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1083 Budapest, Szigony u. 43, Hungary; János Szentágothai School of Neurosciences, Semmelweis University School of Ph.D Studies, Budapest, Hungary.
Cecilia CsölleLaboratory of Molecular Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1083 Budapest, Szigony u. 43, Hungary; János Szentágothai School of Neurosciences, Semmelweis University School of Ph.D Studies, Budapest, Hungary.
Kornél KirályDepartment of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, H-1089 Budapest, Hungary.
Rómeó D AndóLaboratory of Molecular Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1083 Budapest, Szigony u. 43, Hungary.
Mária BaranyiLaboratory of Molecular Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1083 Budapest, Szigony u. 43, Hungary.
Bence KoványiLaboratory of Molecular Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1083 Budapest, Szigony u. 43, Hungary; János Szentágothai School of Neurosciences, Semmelweis University School of Ph.D Studies, Budapest, Hungary.
Zoltán MátéMedical Gene Technology Unit, Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1083 Budapest, Szigony u. 43, Hungary.
Kristina HoffmannDepartment of Pharmacology and Toxicology, University of Bonn, D-53105 Bonn, Germany.
Irina AlgaierDepartment of Pharmacology and Toxicology, University of Bonn, D-53105 Bonn, Germany.
Younis BaqiDepartment of Chemistry, Faculty of Science, Sultan Qaboos University, P. O. Box 36, Postal Code 123, Muscat, Oman; PharmaCenter Bonn, Pharmaceutical Institute, University of Bonn, D-53119, Germany.
Christa E MüllerPharmaCenter Bonn, Pharmaceutical Institute, University of Bonn, D-53119, Germany.
Ivar Von KügelgenDepartment of Pharmacology and Toxicology, University of Bonn, D-53105 Bonn, Germany.
Beáta SperlághLaboratory of Molecular Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1083 Budapest, Szigony u. 43, Hungary. Electronic address: sperlagh@koki.hu.
Hungarian Academy of Sciences · HUUniversity of Bonn · DEHUN-REN Institute of Experimental Medicine · HUSemmelweis University · HU

Funding

European Research Council 294313Wellcome Trust
6 · The paper itself

Abstract

In this study the role of P2Y12 receptors (P2Y12R) was explored in rodent models of inflammatory and neuropathic pain and in acute thermal nociception. In correlation with their activity to block the recombinant human P2Y12R, the majority of P2Y12R antagonists alleviated mechanical hyperalgesia dose-dependently, following intraplantar CFA injection, and after partial ligation of the sciatic nerve in rats. They also caused an increase in thermal nociceptive threshold in the hot plate test. Among the six P2Y12R antagonists evaluated in the pain studies, the selective P2Y12 receptor antagonist PSB-0739 was most potent upon intrathecal application. P2Y12R mRNA and IL-1β protein were time-dependently overexpressed in the rat hind paw and lumbar spinal cord following intraplantar CFA injection. This was accompanied by the upregulation of TNF-α, IL-6 and IL-10 in the hind paw. PSB-0739 (0.3mg/kg i.t.) attenuated CFA-induced expression of cytokines in the hind paw and of IL-1β in the spinal cord. Subdiaphragmatic vagotomy and the α7 nicotinic acetylcholine receptor antagonist MLA occluded the effect of PSB-0739 (i.t.) on pain behavior and peripheral cytokine induction. Denervation of sympathetic nerves by 6-OHDA pretreatment did not affect the action of PSB-0739. PSB-0739, in an analgesic dose, did not influence motor coordination and platelet aggregation. Genetic deletion of the P2Y12R in mice reproduced the effect of P2Y12R antagonists on mechanical hyperalgesia in inflammatory and neuropathic pain models, on acute thermal nociception and on the induction of spinal IL-1β. Here we report the robust involvement of the P2Y12R in inflammatory pain. The anti-hyperalgesic effect of P2Y12R antagonism could be mediated by the inhibition of both central and peripheral cytokine production and involves α7-receptor mediated efferent pathways.

Indexed as

AnalgesicsAnimalsCell Line, TumorChimeraCHO CellsCricetulusCyclic AMPCytokinesDisease Models, AnimalHumansHyperalgesiaMaleMice, Inbred C57BLMice, KnockoutNociceptionPainAnalgesicsCyclic AMPCytokinesP2RY12 protein, humanP2ry12 protein, mouseP2ry12 protein, ratReceptors, Purinergic P2Y12Inflammatory painInterleukin-1βNeuropathic painP2Y(12) receptorPurine receptorSpinal cord

Identifiers

PMID24971933
PMCPMC4148180
OpenAlexW2074152542

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.